Status:
COMPLETED
Fluid Status of ESRD Patients Undergoing Dialysis
Lead Sponsor:
HemoCept Inc.
Conditions:
ESRD (End Stage Renal Disease)
Eligibility:
All Genders
18-75 years
Brief Summary
The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.
Eligibility Criteria
Inclusion
- Subject or representatives must have voluntarily signed the informed consent form before any study related procedures
- Subjects can be any gender, but must be between (and including) 18 and 75 years of age
- Subject has been on dialysis for more than 90 days and has been diagnosed with end stage kidney disease
- Subject is able and willing to provide informed consent and HIPAA authorization.
- Subject is able and willing to meet all study requirements
- Subject is able to place electrodes on bilateral deltoids and above the pant line on the waist.
Exclusion
- Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
- Subject has a personal medical history that includes: Long Q-T syndrome, Cardiac channelopathies, genetic heart defects, Seizures, Acute untreated blood clotting disorders or acute untreated bleeding disorders
- Subject has had a heart transplant.
Key Trial Info
Start Date :
August 18 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2025
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT07217470
Start Date
August 18 2025
End Date
November 20 2025
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sierra Nevad Specialty Care
Reno, Nevada, United States, 89511